A controlled trial of natalizumab for relapsing multiple sclerosis (Q48414534)
scientific article published in January 2003
Language:
Current Data About A controlled trial of natalizumab for relapsing multiple sclerosis
(P31) (Q13442814)
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P50) (Q104696550)
(P1545) 1
(P1932) David H Miller
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P304) 15-23
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P407) (Q1860)

(P433) 1
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P478) 348
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P577) Wednesday, January 1, 2003
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P921) (Q8277)

(P1433) (Q582728)
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P1476) "A controlled trial of natalizumab for relapsing multiple sclerosis" (language: en)
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

(P2093) Omar A Khan
(P1545) 2
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

William A Sheremata
(P1545) 3
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Lance D Blumhardt
(P1545) 4
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

George P A Rice
(P1545) 5
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Michele A Libonati
(P1545) 6
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Allison J Willmer-Hulme
(P1545) 7
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Catherine M Dalton
(P1545) 8
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Katherine A Miszkiel
(P1545) 9
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

Paul W O'Connor
(P1545) 10
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

International Natalizumab Multiple Sclerosis Trial Group
(P1545) 11
(P248)
(P698) 12510038
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/12510038

other details
description scientific article published in January 2003

External Links
(P356) 10.1056/NEJMOA020696
(P698) 12510038
(P5875) 10966474